DXR
Daxor Corporation (DXR)
$
73About Daxor Corporation (DXR)
DAXOR Corporation is an innovative medical instrumentation and biotechnology company. DAXOR designed and developed the BVA-100 Blood Volume Analyzer. It is the first instrument approved by the FDA to provide rapid direct measurement of a patient's true blood volume. We believe that the BVA-100 Blood Volume Analyzer has the potential to transform therapy in a broad range of surgical and medical conditions. It is our goal, working in conjunction with hospitals and clinics, to achieve that possibility. The BVA-100 is a semi-automated Blood Volume Analyzer. It is used in conjunction with a single use diagnostic kit. It is the first FDA-approved instrument to provide rapid direct measurement of a patient's blood volume.
Details
Daily high
$8.80
Daily low
$8.64
Price at open
$8.77
52 Week High
$10.04
52 Week Low
$7.11
Market cap
42.2M
Dividend yield
0.00%
Volume
11,063
Avg. volume
6,840
P/E ratio
24.76
Daxor Corporation News
Details
Daily high
$8.80
Daily low
$8.64
Price at open
$8.77
52 Week High
$10.04
52 Week Low
$7.11
Market cap
42.2M
Dividend yield
0.00%
Volume
11,063
Avg. volume
6,840
P/E ratio
24.76